FRESENIUS SE & CO KGAA (FRE.DE) Fundamental Analysis & Valuation

FRA:FRE • DE0005785604

Current stock price

43.72 EUR
-0.34 (-0.77%)
Last:

This FRE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FRE.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FRE was profitable.
  • FRE had a positive operating cash flow in the past year.
  • FRE had positive earnings in 4 of the past 5 years.
  • FRE had a positive operating cash flow in 4 of the past 5 years.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • FRE has a Return On Assets (2.69%) which is comparable to the rest of the industry.
  • The Return On Equity of FRE (6.14%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 4.44%, FRE is in line with its industry, outperforming 40.74% of the companies in the same industry.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 4.44%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • FRE's Profit Margin of 5.11% is amongst the best of the industry. FRE outperforms 92.59% of its industry peers.
  • In the last couple of years the Profit Margin of FRE has grown nicely.
  • FRE's Operating Margin of 9.76% is amongst the best of the industry. FRE outperforms 92.59% of its industry peers.
  • FRE's Operating Margin has declined in the last couple of years.
  • The Gross Margin of FRE (24.99%) is comparable to the rest of the industry.
  • FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. FRE.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
  • FRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.00 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.00, FRE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of FRE is 11.17, which is on the high side as it means it would take FRE, 11.17 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of FRE (11.17) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
  • The Debt to Equity ratio of FRE (0.61) is better than 85.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2
ROIC/WACC0.85
WACC5.21%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that FRE should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, FRE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • FRE has a Quick Ratio of 1.26. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FRE has a Quick ratio of 0.99. This is in the better half of the industry: FRE outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. FRE.DE Growth Analysis

3.1 Past

  • FRE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.31%.
  • FRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.06% yearly.
  • Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 3.87% in the last year.
  • FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.81% yearly.
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%

3.2 Future

  • Based on estimates for the next years, FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.54% on average per year.
  • The Revenue is expected to grow by 5.03% on average over the next years.
EPS Next Y16.18%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
EPS Next 5Y10.54%
Revenue Next Year4.95%
Revenue Next 2Y4.9%
Revenue Next 3Y5.06%
Revenue Next 5Y5.03%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. FRE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.66, the valuation of FRE can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of FRE indicates a somewhat cheap valuation: FRE is cheaper than 66.67% of the companies listed in the same industry.
  • FRE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.88.
  • Based on the Price/Forward Earnings ratio of 11.76, the valuation of FRE can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, FRE is valued a bit cheaper than the industry average as 74.07% of the companies are valued more expensively.
  • FRE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 13.66
Fwd PE 11.76
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRE.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.54
EV/EBITDA 9.63
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • FRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y13.43%
EPS Next 3Y11.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. FRE.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.38%, FRE has a reasonable but not impressive dividend return.
  • FRE's Dividend Yield is a higher than the industry average which is at 1.94.
  • Compared to an average S&P500 Dividend Yield of 1.89, FRE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FRE.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS SE & CO KGAA

FRA:FRE (3/27/2026, 7:00:00 PM)

43.72

-0.34 (-0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners45.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.62B
Revenue(TTM)22.68B
Net Income(TTM)1.14B
Analysts85.22
Price Target57.32 (31.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)1.68%
PT rev (3m)3.67%
EPS NQ rev (1m)-0.19%
EPS NQ rev (3m)2.1%
EPS NY rev (1m)-2.82%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 13.66
Fwd PE 11.76
P/S 1.1
P/FCF 20.54
P/OCF 11.31
P/B 1.32
P/tB 13.3
EV/EBITDA 9.63
EPS(TTM)3.2
EY7.32%
EPS(NY)3.72
Fwd EY8.5%
FCF(TTM)2.13
FCFY4.87%
OCF(TTM)3.87
OCFY8.84%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)0.84
PEG (5Y)N/A
Graham Number48.79
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 4.44%
ROICexc 5.05%
ROICexgc 11.76%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2
F-Score7
WACC5.21%
ROIC/WACC0.85
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
EPS Next Y16.18%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
EPS Next 5Y10.54%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%
Revenue Next Year4.95%
Revenue Next 2Y4.9%
Revenue Next 3Y5.06%
Revenue Next 5Y5.03%
EBIT growth 1Y51.21%
EBIT growth 3Y7.94%
EBIT growth 5Y-11.93%
EBIT Next Year54.49%
EBIT Next 3Y20.57%
EBIT Next 5Y14.27%
FCF growth 1Y-43.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.77%
OCF growth 3YN/A
OCF growth 5YN/A

FRESENIUS SE & CO KGAA / FRE.DE Fundamental Analysis FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS SE & CO KGAA (FRE.DE) stock?

The Earnings per Share (EPS) of FRESENIUS SE & CO KGAA (FRE.DE) is expected to grow by 16.18% in the next year.


How sustainable is the dividend of FRESENIUS SE & CO KGAA (FRE.DE) stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10 and the dividend payout ratio is 59.84%.